Health AbbVie (ABBV) Alert: Johnson Fistel, Globally-Recognized Law Firm, Encourages Long-Term Shareholders to Submit Their Information June 13, 2022
Health AbbVie Announces Late-Breaking Results from Phase 2 Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL) at the European Hematology Association (EHA) Annual Congress June 11, 2022
Health ABBVIE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of AbbVie Inc. – ABBV June 10, 2022
Health AbbVie Presents Investigational Navitoclax Preliminary Data in JAK Inhibitor Naïve Myelofibrosis Patients June 10, 2022
Search
Search
